The role of TAPSE/sPAP ratio in predicting ...
Document type :
Article dans une revue scientifique: Article de synthèse/Review paper
PMID :
Permalink :
Title :
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort.
Author(s) :
Colalillo, Amalia [Auteur]
Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome] [UNIROMA]
Hoffmann-Vold, Anna-Maria [Auteur]
Oslo University Hospital [Oslo]
Pellicano, Chiara [Auteur]
Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome] [UNIROMA]
Romaniello, Antonella [Auteur]
Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome] [UNIROMA]
Gabrielli, Armando [Auteur]
Polytechnic University of Marche / Università Politecnica delle Marche [UNIVPM]
Hachulla, Eric [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Smith, Vanessa [Auteur]
Ghent University Hospital
Simeón-Aznar, Carmen-Pilar [Auteur]
Vall d'Hebron University Hospital [Barcelona]
Castellví, Ivan [Auteur]
Hospital de la Santa Creu i Sant Pau
Airò, Paolo [Auteur]
Civic Hospital of Brescia
Truchetet, Marie-Elise [Auteur]
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Siegert, Elise [Auteur]
Charité - UniversitätsMedizin = Berlin University Medicine
Distler, Oliver [Auteur]
University hospital of Zurich [Zurich]
Rosato, Edoardo [Auteur]
Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome] [UNIROMA]
Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome] [UNIROMA]
Hoffmann-Vold, Anna-Maria [Auteur]
Oslo University Hospital [Oslo]
Pellicano, Chiara [Auteur]
Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome] [UNIROMA]
Romaniello, Antonella [Auteur]
Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome] [UNIROMA]
Gabrielli, Armando [Auteur]
Polytechnic University of Marche / Università Politecnica delle Marche [UNIVPM]
Hachulla, Eric [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Smith, Vanessa [Auteur]
Ghent University Hospital
Simeón-Aznar, Carmen-Pilar [Auteur]
Vall d'Hebron University Hospital [Barcelona]
Castellví, Ivan [Auteur]
Hospital de la Santa Creu i Sant Pau
Airò, Paolo [Auteur]
Civic Hospital of Brescia
Truchetet, Marie-Elise [Auteur]
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Siegert, Elise [Auteur]
Charité - UniversitätsMedizin = Berlin University Medicine
Distler, Oliver [Auteur]
University hospital of Zurich [Zurich]
Rosato, Edoardo [Auteur]
Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome] [UNIROMA]
Journal title :
Autoimmunity Reviews
Abbreviated title :
Autoimmun Rev
Volume number :
22
Pages :
103290
Publication date :
2023-02-28
ISSN :
1873-0183
English keyword(s) :
TAPSE
sPAP ratio
Systemic sclerosis
Pulmonary hypertension
Right ventricle
sPAP ratio
Systemic sclerosis
Pulmonary hypertension
Right ventricle
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Objectives
The study aim was to evaluate the predictive role of the echocardiography-derived tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/sPAP) ratio for pulmonary hypertension ...
Show more >Objectives The study aim was to evaluate the predictive role of the echocardiography-derived tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/sPAP) ratio for pulmonary hypertension (PH) diagnosis and mortality in the European Scleroderma Trials and Research (EUSTAR) cohort. Methods Eligible patients were systemic sclerosis (SSc) patients registered in the EUSTAR database with at least one visit recording TAPSE and sPAP data. Individual centres were required to provide TAPSE and sPAP data at 12 ± 3 months before right heart catheterization (RHC). Logistic regression analysis was applied to analyse the predictive ability of TAPSE/sPAP ratio for PH diagnosis. Cox regression analysis was performed to evaluate TAPSE/sPAP ratio as a predictive factor for all-cause mortality. Results 2555 SSc patients met the inclusion criteria for this study with 355 SSc patients having available RHC data at baseline. PH was confirmed by RHC in 195 SSc patients (54.9%). TAPSE/sPAP ratio < 0.55 mm/mmHg [OR 0.251 (95% CI 0.084–0.753), p < 0.05] and FVC/DLCO [OR 2.568 (95% CI 1.227–5.375), p < 0.05] were significantly associated with PH diagnosis. In logistic regression analysis with echocardiographic parameters at 12 ± 3 months before RHC, TAPSE/sPAP ratio < 0.55 mm/mmHg [OR 0.265 (95% CI 0.102–0.685), p < 0.01] and FVC/DLCO [OR 2.529 (95% CI 1.358–4.711), p < 0.01] were associated with PH diagnosis. In multivariate Cox regression analysis, TAPSE/sPAP ratio ≤ 0.32 mm/mmHg [HR 0.310 (0.164–0.585), p < 0.001] was the most significant predictive factor for death. Conclusions TAPSE/sPAP ratio < 0.55 mm/mmHg is a predictive risk factor for PH. TAPSE/sPAP ratio ≤ 0.32 mm/mmHg is a predictive risk marker for all-cause mortality.Show less >
Show more >Objectives The study aim was to evaluate the predictive role of the echocardiography-derived tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/sPAP) ratio for pulmonary hypertension (PH) diagnosis and mortality in the European Scleroderma Trials and Research (EUSTAR) cohort. Methods Eligible patients were systemic sclerosis (SSc) patients registered in the EUSTAR database with at least one visit recording TAPSE and sPAP data. Individual centres were required to provide TAPSE and sPAP data at 12 ± 3 months before right heart catheterization (RHC). Logistic regression analysis was applied to analyse the predictive ability of TAPSE/sPAP ratio for PH diagnosis. Cox regression analysis was performed to evaluate TAPSE/sPAP ratio as a predictive factor for all-cause mortality. Results 2555 SSc patients met the inclusion criteria for this study with 355 SSc patients having available RHC data at baseline. PH was confirmed by RHC in 195 SSc patients (54.9%). TAPSE/sPAP ratio < 0.55 mm/mmHg [OR 0.251 (95% CI 0.084–0.753), p < 0.05] and FVC/DLCO [OR 2.568 (95% CI 1.227–5.375), p < 0.05] were significantly associated with PH diagnosis. In logistic regression analysis with echocardiographic parameters at 12 ± 3 months before RHC, TAPSE/sPAP ratio < 0.55 mm/mmHg [OR 0.265 (95% CI 0.102–0.685), p < 0.01] and FVC/DLCO [OR 2.529 (95% CI 1.358–4.711), p < 0.01] were associated with PH diagnosis. In multivariate Cox regression analysis, TAPSE/sPAP ratio ≤ 0.32 mm/mmHg [HR 0.310 (0.164–0.585), p < 0.001] was the most significant predictive factor for death. Conclusions TAPSE/sPAP ratio < 0.55 mm/mmHg is a predictive risk factor for PH. TAPSE/sPAP ratio ≤ 0.32 mm/mmHg is a predictive risk marker for all-cause mortality.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Submission date :
2024-01-11T23:21:57Z
2024-03-04T10:46:08Z
2024-03-04T10:46:08Z
Files
- 1-s2.0-S1568997223000241-main.pdf
- Non spécifié
- Open access
- Access the document